Switching from natalizumab to antiCD20 monoclonal antibodies: Short transition interval is associated with improved outcome.

Autor: Bsteh G; Department of Neurology, Medical University of Vienna, Wien, Austria.; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Wien, Austria., Hoepner R; Department of Neurology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland., Gernert JA; Institute of Clinical Neuroimmunology, LMU Hospital, Ludwig-Maximilian University, Munich, Germany., Berek K; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria., Gradl C; Department of Neurology, Medical University of St. Pölten, St. Pölten, Austria., Kliushnikova D; Department of Neurology, Christian-Doppler University Hospital, Paracelsus Medical University, Salzburg, Austria., Damulina A; Department of Neurology, Medical University of Graz, Graz, Austria., Traxler G; Department of Neurology 2, Med Campus III, Kepler University Hospital GmbH, Linz, Austria., Föttinger F; Department of Neurology, Medical University of Vienna, Wien, Austria.; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Wien, Austria., Habernig S; Department of Neurology, Medical University of Vienna, Wien, Austria.; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Wien, Austria., Krajnc N; Department of Neurology, Medical University of Vienna, Wien, Austria.; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Wien, Austria., Betancourt AXL; Department of Neurology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland., Ponleitner M; Department of Neurology, Medical University of Vienna, Wien, Austria.; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Wien, Austria., Zrzavy T; Department of Neurology, Medical University of Vienna, Wien, Austria.; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Wien, Austria., Deisenhammer F; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria., Di Pauli F; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria., Havla J; Institute of Clinical Neuroimmunology, LMU Hospital, Ludwig-Maximilian University, Munich, Germany., Khalil M; Department of Neurology, Medical University of Graz, Graz, Austria., Kümpfel T; Institute of Clinical Neuroimmunology, LMU Hospital, Ludwig-Maximilian University, Munich, Germany., Wipfler P; Department of Neurology, Christian-Doppler University Hospital, Paracelsus Medical University, Salzburg, Austria., Chan A; Department of Neurology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland., Berger T; Department of Neurology, Medical University of Vienna, Wien, Austria.; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Wien, Austria., Hammer H; Department of Neurology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland., Hegen H; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

Publikováno v: European journal of neurology [Eur J Neurol] 2025 Jan; Vol. 32 (1), pp. e16587.